Well done! Since January 1, 2017, our Society will be affiliated with the European Society of Respiratory Diseases (ERS)
From bench to bedside: DNase in Rhinovirus-induced allergic asthma exacerbation
The most frequent cause of exacerbation in a patient with asthma is the viral respiratory infection. An interesting joint work between Imperial College London and the University of Liege in Belgium published in Nature Medicine suggests new therapeutic targets and the potential use of DNAse in Rhinovirus respiratory infection.
Take a breath of SIMRI air....
Discover the Italian Pediatric Respiratory Society (SIMRI)!
Quick Case opening: the Instructions
Dear SIMRI Members we wish to inform you that following the meeting between a delegation of the Pediatric Assembly ATS and the SIMRI delegation during the last American Thoracic Society (ATS) Congress a collaboration was initiated between the SIMRI website Committees and Pediatric Assembly ATS in order to improve "Education" activities!
A brand new collaboration between SIMRI and ATS
SIMRI and ATS started a new collaboration to provide Italian translation of information material for patients and their families
ERS statement on Obstructive Sleep Disordered Breathing in 1- to 23-month-old children
ERS statement on interventional bronchoscopy in children: what we do and what we can do better
Pulmonary function and asthma risk may depend on fetal and infant growth patterns
Characterization and exacerbation risk of a general asthma population
Tobacco industry and the new candy-flavored products
Episodic viral and multitrigger wheeze: different phenotypes or different diseases?
Decalogue about climate, environment and respiratory health
A New combination therapy against an OLD disease: Tezacaftor-Ivacaftor in CF homozygous for Phe508del patients